Secondary
Leap Therapeutics, Inc.
Leap Therapeutics, Inc. is a biopharmaceutical company focused on developing novel therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways and by harnessing the immune system to attack cancer cells.
Symbol
LPTX
Last Closing Price
$7.50
Anticipated Date
TBD
Underwriters
Raymond James, Ladenburg Thalmann
To view the prospectus for Leap Therapeutics, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277